APA (7th ed.) Citation

Zhong, M., Pan, G., Tan, J., Yao, J., Liu, Y., Huang, J., . . . Zha, J. (2025). Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma. Clinical Epigenetics, 17(1), 1. https://doi.org/10.1186/s13148-025-01878-0

Chicago Style (17th ed.) Citation

Zhong, Mengya, et al. "Venetoclax Confers Synthetic Lethality to Chidamide in Preclinical Models with Transformed Follicular Lymphoma." Clinical Epigenetics 17, no. 1 (2025): 1. https://doi.org/10.1186/s13148-025-01878-0.

MLA (9th ed.) Citation

Zhong, Mengya, et al. "Venetoclax Confers Synthetic Lethality to Chidamide in Preclinical Models with Transformed Follicular Lymphoma." Clinical Epigenetics, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13148-025-01878-0.